Profile data is unavailable for this security.
About the company
Koninklijke Philips NV is the Netherlands-based health technology company. The Company's segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease. The Diagnosis & Treatment businesses segment delivers precision medicine and treatment, and therapy. The Connected Care & Health Informatics businesses segment provides consumers, care givers and clinicians with digital solutions that facilitate care by enabling precision medicine and population health management. The HealthTech Other segment comprises such items, as innovation, emerging businesses, royalties, among others. The Legacy Items segment consists mainly of separation costs, legacy legal items, legacy pension costs, among others.
- Revenue in EUR (TTM)18.17bn
- Net income in EUR-455.00m
- Incorporated2000
- Employees69.66k
- LocationRoyal PhilipsHigh Tech Campus 5EINDHOVEN 5656 AENetherlandsNLD
- Phone+31 205977777
- Fax+31 205977220
- Websitehttps://www.philips.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Demant A/S | 3.01bn | 342.03m | 9.30bn | 21.62k | 27.44 | 7.48 | -- | 3.09 | 11.44 | 8.05 | 100.58 | 41.97 | 0.7431 | 2.05 | 5.88 | 1,037,923.00 | 8.46 | 8.27 | 12.20 | 13.23 | 73.72 | 74.14 | 11.38 | 11.34 | 0.9529 | 5.98 | 0.6075 | 0.00 | 13.89 | 10.00 | 12.23 | 6.96 | 8.80 | -- |
| Smith & Nephew plc | 5.20bn | 246.46m | 9.77bn | 18.45k | 39.60 | 1.99 | 11.03 | 1.88 | 0.242 | 0.242 | 5.11 | 4.81 | 0.5562 | 0.7522 | 4.33 | 241,624.50 | 2.64 | 4.10 | 3.29 | 4.99 | 68.82 | 71.39 | 4.74 | 8.02 | 0.72 | 4.84 | 0.3715 | 79.59 | 6.40 | 2.50 | 17.94 | -16.88 | 4.24 | -8.12 |
| Sonova Holding AG | 3.75bn | 617.77m | 15.30bn | 17.64k | 24.83 | 7.05 | 17.43 | 4.08 | 10.05 | 10.05 | 61.01 | 35.39 | 0.6887 | 2.44 | 7.04 | 206,996.80 | 11.56 | 10.87 | 14.70 | 13.94 | 71.77 | 71.75 | 16.78 | 17.80 | 0.9036 | 24.86 | 0.4646 | 34.54 | 11.13 | 7.16 | 1.08 | 9.79 | 9.89 | 12.09 |
| Koninklijke Philips NV | 18.17bn | -455.00m | 17.30bn | 69.66k | -- | 1.43 | 23.90 | 0.9522 | -0.4979 | -0.5097 | 19.55 | 13.27 | 0.6047 | 2.84 | 4.63 | 260,853.30 | -1.51 | 0.3678 | -2.07 | 0.5013 | 41.00 | 43.84 | -2.49 | 0.6049 | 0.7782 | 5.36 | 0.3893 | -- | 1.92 | 0.0529 | 71.87 | -- | -5.24 | -- |
| Straumann Holding AG | 2.48bn | 253.15m | 22.15bn | 11.11k | 87.57 | 11.72 | 57.09 | 8.93 | 1.54 | 1.54 | 15.11 | 11.52 | 0.7204 | 1.81 | 4.29 | 217,105.00 | 7.37 | 10.68 | 9.86 | 13.63 | 74.15 | 74.95 | 10.23 | 15.15 | 1.43 | 6.72 | 0.1968 | 37.50 | 3.92 | 12.08 | -43.40 | -2.04 | 11.54 | 10.12 |
| Sartorius Stedim Biotech SA | 2.78bn | 309.70m | 24.20bn | 10.66k | 73.96 | 8.69 | 44.01 | 8.72 | 3.36 | 3.36 | 30.14 | 28.62 | 0.4335 | 1.62 | 7.95 | 260,317.00 | 4.88 | 11.87 | 5.82 | 15.12 | 44.44 | 50.96 | 11.25 | 17.44 | 0.5683 | 11.55 | 0.5794 | 18.73 | -20.53 | 18.02 | -64.65 | 8.28 | 21.82 | 3.90 |
| Coloplast A/S | 3.35bn | 652.43m | 25.37bn | 15.75k | 40.12 | 13.38 | 31.63 | 7.57 | 22.44 | 22.44 | 115.20 | 67.27 | 0.5794 | 2.40 | 5.99 | 1,593,232.00 | 11.28 | 20.45 | 17.11 | 29.69 | 66.74 | 67.91 | 19.47 | 21.73 | 0.3462 | 11.08 | 0.5885 | 91.08 | 8.51 | 8.29 | 1.64 | 4.46 | 13.15 | 5.59 |
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 31 Dec 2023 | 48.65m | 5.33% |
| The Vanguard Group, Inc.as of 05 Apr 2024 | 28.19m | 3.09% |
| UBS Asset Management (UK) Ltd.as of 01 Mar 2024 | 23.11m | 2.53% |
| BlackRock Investment Management LLCas of 11 Apr 2024 | 21.13m | 2.31% |
| Norges Bank Investment Managementas of 31 Dec 2023 | 17.53m | 1.92% |
| BlackRock Fund Advisorsas of 04 Apr 2024 | 13.88m | 1.52% |
| Amundi Asset Management SA (Investment Management)as of 03 Nov 2022 | 13.29m | 1.46% |
| Causeway Capital Management LLCas of 31 Mar 2024 | 12.84m | 1.41% |
| Edgepoint Investment Group, Inc.as of 31 Dec 2023 | 10.82m | 1.19% |
| UBS Asset Management (Americas) LLCas of 11 Apr 2024 | 7.95m | 0.87% |
